Get the Stockscreener App
2.72
0.74%
0.02
After Hours:
2.74
0.02
+0.74%
Kiora Pharmaceuticals Inc stock is traded at $2.72, with a volume of 29,828.
It is up +0.74% in the last 24 hours and up +3.03% over the past month.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
See More
Previous Close:
$2.70
Open:
$2.71
24h Volume:
29,828
Relative Volume:
0.53
Market Cap:
$9.34M
Revenue:
-
Net Income/Loss:
$2.81M
P/E Ratio:
-0.1896
EPS:
-14.3497
Net Cash Flow:
$7.14M
1W Performance:
-0.73%
1M Performance:
+3.03%
6M Performance:
+2.26%
1Y Performance:
-20.93%
1-Day Range:
$2.66
$2.80
1-Week Range:
$2.65
$2.95
52-Week Range:
$2.25
$4.18
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Name
Kiora Pharmaceuticals Inc
Sector
Industry
Phone
858-224-9600
Address
169 SAXONY RD., ENCINITAS
Compare KPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
2.72 | 9.27M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Kiora Pharmaceuticals Inc Stock (KPRX) Latest News
When is the best time to exit Kiora Pharmaceuticals Inc.Weekly Trade Report & Fast Entry Momentum Trade Alerts - newser.com
Can Kiora Pharmaceuticals Inc. stock double in next 5 yearsGap Down & Free AI Powered Buy and Sell Recommendations - newser.com
Will earnings trigger a reversal in Kiora Pharmaceuticals Inc.Portfolio Gains Report & Proven Capital Preservation Methods - newser.com
Is Kiora Pharmaceuticals Inc. stock ready for a breakoutMarket Volume Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Will Kiora Pharmaceuticals Inc. rebound enough to break evenJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com
Intraday pattern recognizer results for Kiora Pharmaceuticals Inc.Market Growth Review & Fast Exit and Entry Trade Guides - newser.com
Is Kiora Pharmaceuticals Inc. stock bottoming out2025 Key Lessons & Free Real-Time Market Sentiment Alerts - newser.com
Tools to monitor Kiora Pharmaceuticals Inc. recovery probabilitySwing Trade & Community Consensus Picks - newser.com
Applying Wyckoff theory to Kiora Pharmaceuticals Inc. stockPortfolio Value Report & Technical Pattern Alert System - newser.com
Can volume confirm reversal in Kiora Pharmaceuticals Inc.Earnings Overview Report & Stock Market Timing Techniques - newser.com
How to forecast Kiora Pharmaceuticals Inc. trends using time series2025 Support & Resistance & Real-Time Stock Movement Alerts - newser.com
Using Python tools to backtest Kiora Pharmaceuticals Inc. strategies2025 Earnings Surprises & Low Risk Entry Point Guides - newser.com
Will Kiora Pharmaceuticals Inc. (7EY) stock hit analyst forecastsWeekly Investment Report & Growth Oriented Trading Recommendations - newser.com
Can Kiora Pharmaceuticals Inc. (7EY) stock double in coming yearsWeekly Trade Recap & Entry Point Confirmation Alerts - newser.com
Will Kiora Pharmaceuticals Inc. (7EY) stock justify high valuationJuly 2025 Recap & Fast Entry Momentum Alerts - newser.com
How analysts revise price targets for Kiora Pharmaceuticals Inc. (7EY) stockWeekly Profit Analysis & Reliable Volume Spike Alerts - newser.com
Live market analysis of Kiora Pharmaceuticals Inc.Insider Selling & Stock Portfolio Risk Management - newser.com
Top chart patterns to watch in Kiora Pharmaceuticals Inc.Recession Risk & Weekly High Potential Stock Alerts - newser.com
Kiora Pharmaceuticals Inc 7EY Stock Analysis and ForecastLarge Cap Stability Picks & Reinvest for Maximum Compounding Returns - earlytimes.in
What drives Kiora Pharmaceuticals Inc stock priceTrading Volume Surges & Explore Stocks for Free with Our Research Portal - earlytimes.in
Kiora Pharmaceuticals Inc Stock (KPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):